PDF
SAT0165 Low-dose IL-2 therapy selectively expands regulatory T cells and suppresses murine lupus
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address